Detection of Clostridium difficile toxins A and B in inpatient stool samples by enzyme-linked fluorescent immunoassay

Feng Zhenru
2012-01-01
Abstract:Objective To detect Clostridium difficile toxins A/B(CDAB) in stool samples of inpatients by enzyme-linked fluorescent immunoassay(ELFIA) and PCR and analyze the yields of CDAB in stool samples from inpatients with different clinical features.Methods The stool samples from 242 inpatients of Peking University First Hospital were collected from August to November 2010.CDAB was detected by ELFIA and the equivocal samples were retested by PCR.The inpatients were divided into 2 groups: non-antibiotic associated diarrhea(NAAD) and antibiotic associated diarrhea(AAD).The CDAB positive rates of 2 groups were compared by chi-square test.The correlation of laboratory results and clinical features were analyzed.Results Among the 242 inpatient samples studied,22 were toxins-positive and 12 were equivocal.Ten of 12 equivocal samples were retested by PCR and 8(80.0%) were positive for the toxin genes.Totally 30(12.4%) samples were defined as the toxin-positive by combined two methods.The toxin-positive rate(24.0%) in AAD group was significantly higher than that(6.9%) of NAAD group(χ2= 14.21,P0.01).The age of patients of CDAB-positive group was older [(68.2±23.6) years old] than those(58.7±23.4) of CDAB-negative group(P0.05).Conclusions The commercial kit using ELFIA was convenient and reliable for detection of CDAB.Retesting the equivocal samples by PCR for tcdA/tcdB genes could raise the positive rate.The positive rate of CDI was higher in AAD patients which highly correlated with the clinical features of inpatients.
What problem does this paper attempt to address?